Background: The concept of a dynamic risk-stratification scheme has been suggested for
individualized management of patients with papillary thyroid carcinoma (PTC). However …

Background: About 20% of patients with papillary thyroid carcinoma (PTC) submitted to total
thyroidectomy followed by radioactive iodine (RAI) exhibit an indeterminate response to …

The clinical outcome of papillary thyroid carcinoma (PTC) patients with an indeterminate
response after initial therapy is reported to be intermediate, between incomplete and …

Objective In view of the low probability of recurrence, the cost‐effective follow‐up of patients
with papillary thyroid carcinoma (PTC) of low or intermediate risk and excellent response to …

Background: In papillary thyroid carcinoma (PTC), recurrences during long-term follow-up (R-
LTFU) occur even in those who appear to have an excellent prognosis after initial thyroid …

Abstract Background Although the 2015 American Thyroid Association guidelines proposed
initial and response-to-therapy risk stratifications were adequately validated in untreated …

Objectives: The aims of this study were to validate the proposed Latin American Thyroid
Society (LATS) risk of recurrence stratification system and to compare the findings with those …

Background: According to American Thyroid Association (ATA), all patients with papillary
thyroid carcinoma (PTC) should initially be classified regarding the risk of tumor recurrence …

Objective The dynamic risk stratification (DRS) and its current definition of each response‐to‐
therapy category in post‐lobectomy papillary thyroid carcinoma (PTC) patients have not …

Background Papillary thyroid cancer (PTC) has an excellent prognosis, and recurrence is
rare in patients with no evidence of disease (NED) after initial treatment. Despite this …